245 related articles for article (PubMed ID: 36680239)
1. Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action.
Abbadi N; Mousa JJ
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680239
[TBL] [Abstract][Full Text] [Related]
2. Anti-neuraminidase immunity in the combat against influenza.
Zhang X; Ross TM
Expert Rev Vaccines; 2024; 23(1):474-484. PubMed ID: 38632930
[TBL] [Abstract][Full Text] [Related]
3. Targeting neuraminidase: the next frontier for broadly protective influenza vaccines.
Wu NC; Ellebedy AH
Trends Immunol; 2024 Jan; 45(1):11-19. PubMed ID: 38103991
[TBL] [Abstract][Full Text] [Related]
4. Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells.
Piepenbrink MS; Nogales A; Basu M; Fucile CF; Liesveld JL; Keefer MC; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
mBio; 2019 Mar; 10(2):. PubMed ID: 30862743
[TBL] [Abstract][Full Text] [Related]
5. Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase.
Lei R; Kim W; Lv H; Mou Z; Scherm MJ; Schmitz AJ; Turner JS; Tan TJC; Wang Y; Ouyang WO; Liang W; Rivera-Cardona J; Teo C; Graham CS; Brooke CB; Presti RM; Mok CKP; Krammer F; Dai X; Ellebedy AH; Wu NC
Immunity; 2023 Nov; 56(11):2621-2634.e6. PubMed ID: 37967533
[TBL] [Abstract][Full Text] [Related]
6. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
7. Influenza B virus neuraminidase: a potential target for next-generation vaccines?
Do THT; Wheatley AK; Kent SJ; Koutsakos M
Expert Rev Vaccines; 2024; 23(1):39-48. PubMed ID: 38037386
[TBL] [Abstract][Full Text] [Related]
8. Inactivated influenza virions are a flexible vaccine platform for eliciting protective antibody responses against neuraminidase.
Martinez MR; Gao J; Wan H; Kang H; Klenow L; Daniels R
Vaccine; 2023 Jun; 41(29):4302-4312. PubMed ID: 37301705
[TBL] [Abstract][Full Text] [Related]
9. The Potential of Neuraminidase as an Antigen for Nasal Vaccines To Increase Cross-Protection against Influenza Viruses.
Kawai A; Yamamoto Y; Nogimori T; Takeshita K; Yamamoto T; Yoshioka Y
J Virol; 2021 Sep; 95(20):e0118021. PubMed ID: 34379511
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
11. Broadly neutralizing antibodies to combat influenza virus infection.
Sun X; Ma H; Wang X; Bao Z; Tang S; Yi C; Sun B
Antiviral Res; 2024 Jan; 221():105785. PubMed ID: 38145757
[TBL] [Abstract][Full Text] [Related]
12. Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza.
Werninghaus IC; Hinke DM; Fossum E; Bogen B; Braathen R
Mol Ther; 2023 Jul; 31(7):2188-2205. PubMed ID: 36926694
[TBL] [Abstract][Full Text] [Related]
13. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
[TBL] [Abstract][Full Text] [Related]
14. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
Skarlupka AL; Bebin-Blackwell AG; Sumner SF; Ross TM
J Virol; 2021 Aug; 95(17):e0075921. PubMed ID: 34160258
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.
Eichelberger MC; Monto AS
J Infect Dis; 2019 Apr; 219(Suppl_1):S75-S80. PubMed ID: 30715357
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice.
Wohlbold TJ; Nachbagauer R; Xu H; Tan GS; Hirsh A; Brokstad KA; Cox RJ; Palese P; Krammer F
mBio; 2015 Mar; 6(2):e02556. PubMed ID: 25759506
[TBL] [Abstract][Full Text] [Related]
17. Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.
Zost SJ; Wu NC; Hensley SE; Wilson IA
J Infect Dis; 2019 Apr; 219(Suppl_1):S38-S45. PubMed ID: 30535315
[TBL] [Abstract][Full Text] [Related]
18. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
[TBL] [Abstract][Full Text] [Related]
19. A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases.
Yasuhara A; Yamayoshi S; Kiso M; Sakai-Tagawa Y; Okuda M; Kawaoka Y
Nat Commun; 2022 Nov; 13(1):6602. PubMed ID: 36329075
[TBL] [Abstract][Full Text] [Related]
20. Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model.
Tan J; O'Dell G; Hernandez MM; Sordillo EM; Kahn Z; Kriti D; van Bakel H; Ellebedy AH; Wilson PC; Simon V; Krammer F; McMahon M
J Virol; 2022 Jan; 96(2):e0142121. PubMed ID: 34669506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
